vimarsana.com
Home
Live Updates
2022-06-10 | NDAQ:GTBP | Press Release | GT Biopharma Inc. : comparemela.com
2022-06-10 | NDAQ:GTBP | Press Release | GT Biopharma Inc.
(2022-06-10 | NDAQ:GTBP) GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress
Related Keywords
United States ,
Brisbane ,
Queensland ,
Australia ,
American ,
Biopharma Closecurlyquote ,
Corey Davis ,
Jeff Miller Closecurlyquote ,
Gregory Berk ,
Globe Newswire Gt Biopharma Inc ,
European Hematology Association ,
Company Closecurlydoublequote ,
Nasdaq ,
Exchange Commission ,
Company Closecurlyquote ,
Congress Poster Details ,
University Of Minnesota ,
Gt Biopharma Inc ,
American Cancer Society ,
Tri Specific Killer Engager Drives Robust ,
Function Againstb Cell Malignancies ,
Chief Medical Officer ,
Poster Details ,
Relations Contacts ,
Healthcare 37 ,
Biotechnology 121 ,
Diagnostics Research 128 ,
Usa 8 ,
Biotechnology 70569 ,
comparemela.com © 2020. All Rights Reserved.